Verista acquires Hawkins Points
Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing
Verista, a compliance, automation and packaging solutions organization for the life sciences industry, has acquired Hawkins Point, a provider of life sciences business and technology services. The deal expands upon Verista’s capabilities, adding research and development (R&D) and commercialization technology services for large pharma, early-stage biotech and medical device companies.
The addition of Hawkins Point leverages Verista’s pedigree in FDA-regulated services in information technology (IT) and manufacturing technology. It completes Verista’s lifecycle support for life sciences companies, which consists of consulting, technology and manufacturing services—from early-stage research through commercialization and more.
Adding Hawkins Point’s 100-plus associates brings Verista’s total number of employees to about 500.
The Digital Transformation Reshaping Hospitals and Medication Management
January 20th 2025Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.
